Condemning the pro-abortion policies of the Biden administration.
Impact
The resolution indicates that recent changes, such as allowing pharmacies to dispense mifepristone without in-person visits, could lead to increased health risks for women and girls. Specifically, it contends that without necessary medical supervision, conditions like ectopic pregnancies could go undiagnosed, potentially leading to severe complications. Additionally, the resolution emphasizes that these policy adjustments could disproportionately affect women and girls in remote areas who may struggle to access emergency medical care when needed.
Summary
House Resolution 1285, introduced on June 7, 2024, addresses concerns surrounding the abortion drug mifepristone and denounces the pro-abortion policies of the Biden administration. The resolution outlines specific criticisms regarding the changes made by the Commissioner of Food and Drugs, which have allegedly reduced critical safety protocols for prescribing this medication. Notably, these modifications include the removal of the requirement for in-person dispensing by healthcare providers and easing access regulations, which supporters argue may compromise patient safety and wellbeing.
Contention
Supporters of the resolution claim that eliminating stringent safety measures enables reproductive coercion and endangers women's health. They point to cases where mifepristone has been misused, asserting that decreased oversight allows for instances where it could be exploited by abusers or traffickers. Conversely, opponents of the resolution likely advocate for broader access to abortion medications, stressing the importance of reproductive rights and autonomy, thus revealing a broader national debate regarding women's healthcare access and safety standards.
Expressing support for the designation of June 19, 2024, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.
Recognizing that Adriana Smith and her family's prolonged ordeal without their consent is the direct result of the Black maternal health crisis, the danger of laws that give rights to fetuses and take them away from pregnant people, and anti-abortion laws that continue to harm people who can become pregnant.
Providing the sense of the House of Representatives that the political persecution of President Donald J. Trump is morally unjustifiable and has damaged institutional trust to an extraordinary degree; that the Biden administration's weaponization of the Federal Government against Donald Trump, the Republican Party's nominee for President in 2024, must end; that those responsible for the persecution of Donald Trump within the Biden administration must be held accountable by Congress; and that the United States would benefit enormously from having Donald J. Trump inaugurated once again as the President of the United States on January 20, 2025.
Denouncing the Biden administration's open-borders policies, condemning the national security and public safety crisis along the southwest border, and urging President Biden to end his administration's open-borders policies.
A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.